BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7741828)

  • 1. [A specialized outpatient foot clinic for patients with diabetes decreases the number of amputations and is cost-saving].
    Post D
    Ned Tijdschr Geneeskd; 1994 May; 138(21):1093. PubMed ID: 7741828
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of a diabetic foot screening and protection programme.
    McCabe CJ; Stevenson RC; Dolan AM
    Diabet Med; 1998 Jan; 15(1):80-4. PubMed ID: 9472868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Economic aspects of the diabetic foot syndrome].
    Cechurová D; Lacigová S; Rusavý Z; Horáková N; Jankovec Z; Zourek M
    Vnitr Lek; 2003 Jun; 49(6):453-6. PubMed ID: 14503473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Calculation of the costs of drugs, medical materials, certain medical procedures and social services for patients with diabetic foot syndrome].
    Brunerová L; Andĕl M
    Vnitr Lek; 2003 Jun; 49(6):457-64. PubMed ID: 14503474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multidisciplinary diabetic foot protocol at Chiang Mai University Hospital: cost and quality of life.
    Rerkasem K; Kosachunhanun N; Tongprasert S; Guntawongwan K
    Int J Low Extrem Wounds; 2009 Sep; 8(3):153-6. PubMed ID: 19703951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific problems of the diabetic foot in developing countries.
    Ramachandran A
    Diabetes Metab Res Rev; 2004; 20 Suppl 1():S19-22. PubMed ID: 15150808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A specialized outpatient foot clinic for diabetic patients decreases the number of amputations and is cost saving].
    Bakker K; Dooren J
    Ned Tijdschr Geneeskd; 1994 Mar; 138(11):565-9. PubMed ID: 8139722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness analysis of a worksite clinic: is it worth the cost?
    Chenoweth DH; Garrett J
    AAOHN J; 2006 Feb; 54(2):84-9; quiz 90-1. PubMed ID: 16509183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Reimbursement and importance of hyperbaric oxygenation for diabetic foot ulcers in German publically funded ambulatory health care].
    Gawlik C; Schmacke N; Gibis B; Sander G; Rheinberger P
    Z Arztl Fortbild Qualitatssich; 2001 Nov; 95(10):715-8. PubMed ID: 11778324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost burden to diabetic patients with foot complications--a study from southern India.
    Shobhana R; Rao PR; Lavanya A; Vijay V; Ramachandran A
    J Assoc Physicians India; 2000 Dec; 48(12):1147-50. PubMed ID: 11280217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Editorial in response to the article by D. Cechurová et al.: "Economic aspects of the diabetic foot syndrome"].
    Jirkovská A
    Vnitr Lek; 2003 Jun; 49(6):439-41. PubMed ID: 14503468
    [No Abstract]   [Full Text] [Related]  

  • 12. The diabetic foot: a major problem for the new millennium.
    Boulton AJ
    West Indian Med J; 2001 Mar 1-4; 50 Suppl 1():21-3. PubMed ID: 15973810
    [No Abstract]   [Full Text] [Related]  

  • 13. [Necessary multidisciplinary management of diabetic foot].
    Got I
    J Mal Vasc; 2001 Apr; 26(2):130-4. PubMed ID: 11319420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Foot problems and foot care practices in diabetes. A survey of public and private diabetes clinics affiliated with a university hospital.
    Pugh KB; Jenkins AJ; Zheng D; Chinniss S; Hermayer K; Jenkins C
    J S C Med Assoc; 2002 Dec; 98(8):305-10. PubMed ID: 12532656
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost-effectiveness modeling of Dermagraft for the treatment of diabetic foot ulcers in the french context.
    Allenet B; Parée F; Lebrun T; Carr L; Posnett J; Martini J; Yvon C
    Diabetes Metab; 2000 Apr; 26(2):125-32. PubMed ID: 10804327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Patient classification and analysis of risk profiles for type 2 diabetics as the main focus point in practice. Results of the TEMPO study].
    Lippmann-Grob B; Bierwirth RA; Kron P; Leinhos B; Funke K; Huptas M; Grüneberg M; Weich KW; Münscher C; Potthoff F
    Dtsch Med Wochenschr; 2004 Jan; 129(3):75-81. PubMed ID: 14724780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evidence-based model comparing the cost-effectiveness of platelet-rich plasma gel to alternative therapies for patients with nonhealing diabetic foot ulcers.
    Dougherty EJ
    Adv Skin Wound Care; 2008 Dec; 21(12):568-75. PubMed ID: 19065083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes mellitus and the elderly: special considerations for foot ulcer prevention and care.
    Van Gils CC; Stark LA
    Ostomy Wound Manage; 2006 Sep; 52(9):50-2, 54, 56. PubMed ID: 16980729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic aspects of diabetic foot care in a multidisciplinary setting: a review.
    Matricali GA; Dereymaeker G; Muls E; Flour M; Mathieu C
    Diabetes Metab Res Rev; 2007 Jul; 23(5):339-47. PubMed ID: 17103490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Care of patients with the diabetic foot syndrome based on an international consensus].
    Jirkovská A
    Cas Lek Cesk; 2001 Apr; 140(8):230-3. PubMed ID: 11392039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.